Unlike cervical cancer, endometrial cancer often presents with symptoms at an early stage, per the Mayo Clinic, resulting in ...

Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...

Endometrial cancer usually returns within three years after treatment. Most of the studies that looked at recurrence rates lasted less than five years, so it's hard to know exactly how many ...

An international study led by MHH compares genomic data from national biobanks worldwide and identifies new risk factors in DNA that promote tumor development in the lining of the uterus.

The treatment combines pembrolizumab, made by Merck Sharp & Dohme, with chemotherapy drugs carboplatin and paclitaxel. Pembrolizumab is an immunotherapy that helps the immune system recognise and ...

Endometrial cancer is a disease in which cancerous cells form in the tissues of the endometrium, which is part of the uterus. Huntsman Cancer Institute’s Gynecologic Cancers Program provides ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

That’s a disturbing development, especially in light of the fact that endometrial cancer is the most common gynecologic cancer in the U.S., with some 69,000 new cases and 14,000 deaths estimated ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...

Understanding Obesity and Endometrial Cancer Risk: Opportunities for Prevention Schmandt RE, Iglesias DA, Co NN, Lu KH Am J Obstet Gynecol. 2011;205:518-525 ...

GLP-1 agonist users had a 17% lower cancer risk compared to non-users in a large retrospective study. The reductions achieved ...

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can ...